FDA approves new cholesterol drug

The U.S. Food and Drug Administration has approved a new medication called Liphindera from Merck for cholesterol treatment. It reduces cholesterol levels by more than 50% compared to a placebo. This drug aims to significantly improve cholesterol management, thereby enhancing heart health and reducing risks associated with high cholesterol.